Literature DB >> 24836944

Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: molecular diversity, mutation frequency and antibiotic resistance.

P G Vidigal1, S Dittmer1, E Steinmann2, J Buer1, P-M Rath1, J Steinmann3.   

Abstract

Due to the continuous exposure to a challenging environment and repeated antibiotic treatment courses, bacterial populations in cystic fibrosis (CF) patients experience selective pressure causing the emergence of mutator phenotypes. In this study we investigated the genotypic diversity, mutation frequency and antibiotic resistance of S. maltophilia isolates chronically colonizing CF patients. S. maltophilia was isolated from a total of 90 sputum samples, collected sequentially from 19 CF patients admitted between January 2008 and March 2012 at the University Hospital Essen, Germany. DNA fingerprinting by repetitive-sequence-based PCR revealed that 68.4% (n=13) of CF patients harbored different S. maltophilia genotypes during the 4-year study course. Out of 90 S. maltophilia isolates obtained from chronically colonized CF patients, 17.8% (n=16) were hypomutators, 27.7% (n=25), normomutators, 23.3% (n=21), weak hypermutators and 31.2% (n=28) strong hypermutators. We also found that mutation rates of the most clonally related genotypes varied over time with the tendency to become less mutable. Mutator isolates were found to have no significant increase in resistance against eight different antibiotics versus nonmutators. Sequencing of the mismatch repair genes mutL, mutS and uvrD revealed alterations that resulted in amino acid changes in their corresponding proteins. Here, we could demonstrate that several different S. maltophilia genotypes are present in CF patients and as a sign of adaption their mutation status switches over time to a less mutator phenotype without increasing resistance. These results suggest that S. maltophilia attempts to sustain its biological fitness as mechanism for long-term persistence in the CF lung.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Cystic fibrosis; Mutation frequency; Rep-PCR; Stenotrophomonas maltophilia

Mesh:

Year:  2014        PMID: 24836944     DOI: 10.1016/j.ijmm.2014.04.002

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  12 in total

1.  Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals.

Authors:  Sadia H Sarzynski; Sarah Warner; Junfeng Sun; Roland Matsouaka; John P Dekker; Ahmed Babiker; Willy Li; Yi Ling Lai; Robert L Danner; Vance G Fowler; Sameer S Kadri
Journal:  Open Forum Infect Dis       Date:  2022-01-17       Impact factor: 3.835

Review 2.  Lipopolysaccharide modification in Gram-negative bacteria during chronic infection.

Authors:  Rita F Maldonado; Isabel Sá-Correia; Miguel A Valvano
Journal:  FEMS Microbiol Rev       Date:  2016-04-12       Impact factor: 16.408

Review 3.  Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients' Lung.

Authors:  Quentin Menetrey; Pauline Sorlin; Estelle Jumas-Bilak; Raphaël Chiron; Chloé Dupont; Hélène Marchandin
Journal:  Genes (Basel)       Date:  2021-04-21       Impact factor: 4.096

4.  Friends or foes: can we make a distinction between beneficial and harmful strains of the Stenotrophomonas maltophilia complex?

Authors:  Gabriele Berg; Jose L Martinez
Journal:  Front Microbiol       Date:  2015-03-31       Impact factor: 5.640

5.  Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient.

Authors:  Arianna Pompilio; Valentina Crocetta; Dipankar Ghosh; Malabika Chakrabarti; Giovanni Gherardi; Luca Agostino Vitali; Ersilia Fiscarelli; Giovanni Di Bonaventura
Journal:  Front Microbiol       Date:  2016-09-30       Impact factor: 5.640

6.  Contribution of increased mutagenesis to the evolution of pollutants-degrading indigenous bacteria.

Authors:  Tanel Ilmjärv; Eve Naanuri; Maia Kivisaar
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

7.  Molecular Epidemiology, Antibiotic Resistance, and Virulence Traits of Stenotrophomonas maltophilia Strains Associated With an Outbreak in a Mexican Tertiary Care Hospital.

Authors:  Ariadnna Cruz-Córdova; Jetsi Mancilla-Rojano; Víctor M Luna-Pineda; Gerardo Escalona-Venegas; Vicenta Cázares-Domínguez; Christopher Ormsby; Isabel Franco-Hernández; Sergio Zavala-Vega; Mónica Andrés Hernández; Marisol Medina-Pelcastre; Israel Parra-Ortega; Daniela De la Rosa-Zamboni; Sara A Ochoa; Juan Xicohtencatl-Cortes
Journal:  Front Cell Infect Microbiol       Date:  2020-02-18       Impact factor: 5.293

8.  Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study.

Authors:  Alfonso Esposito; Arianna Pompilio; Clotilde Bettua; Valentina Crocetta; Elisabetta Giacobazzi; Ersilia Fiscarelli; Olivier Jousson; Giovanni Di Bonaventura
Journal:  Front Microbiol       Date:  2017-08-28       Impact factor: 5.640

9.  Analysis of Phylogenetic Variation of Stenotrophomonas maltophilia Reveals Human-Specific Branches.

Authors:  Joerg Steinmann; Uwe Mamat; Ebrahim M Abda; Lisa Kirchhoff; Wolfgang R Streit; Ulrich E Schaible; Stefan Niemann; Thomas A Kohl
Journal:  Front Microbiol       Date:  2018-04-26       Impact factor: 5.640

10.  Taxonogenomics reveal multiple novel genomospecies associated with clinical isolates of Stenotrophomonas maltophilia.

Authors:  Prashant P Patil; Sanjeet Kumar; Samriti Midha; Vikas Gautam; Prabhu B Patil
Journal:  Microb Genom       Date:  2018-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.